Department of Diagnosis and Treatment Services, Radiodiagnostics, Azienda Ospedaliero Universitaria Maggiore della Carità, Novara, Italy.
Department of Diagnosis and Treatment Services, Radiodiagnostics, Azienda Ospedaliero Universitaria Maggiore della Carità, Novara, Italy.
Eur J Radiol. 2020 Sep;130:109192. doi: 10.1016/j.ejrad.2020.109192. Epub 2020 Jul 25.
The goal of this study was to assess chest computed tomography (CT) diagnostic accuracy in clinical practice using RT-PCR as standard of reference.
From March 4th to April 9th 2020, during the peak of the Italian COVID-19 epidemic, we enrolled a series of 773 patients that performed both non-contrast chest CT and RT-PCR with a time interval no longer than a week due to suspected SARS-CoV-2 infection. The diagnostic performance of CT was evaluated according to sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV) and diagnostic accuracy, considering RT-PCR as the reference standard. An analysis on the patients with discrepant CT scan and RT-PCR result and on the patient with both negative tests was performed.
RT-PCR testing showed an overall positive rate of 59.8 %. CT sensitivity, specificity, PPV, NPV, and accuracy for SARS-CoV-2 infection were 90.7 % [95 % IC, 87.7%-93.2%], 78.8 % [95 % IC, 73.8-83.2%], 86.4 % [95 % IC, 76.1 %-88.9 %], 85.1 % [95 % IC, 81.0 %-88.4] and 85.9 % [95 % IC 83.2-88.3%], respectively. Twenty-five/66 (37.6 %) patients with positive CT and negative RT-PCR results and 12/245 (4.9 %) patients with both negative tests were nevertheless judged as positive cases by the clinicians based on clinical and epidemiological criteria and consequently treated.
In our experience, in a context of high pre-test probability, CT scan shows good sensitivity and a consistently higher specificity for the diagnosis of COVID-19 pneumonia than what reported by previous studies, especially when clinical and epidemiological features are taken into account.
本研究旨在评估在临床实践中使用 RT-PCR 作为参考标准的胸部计算机断层扫描(CT)诊断准确性。
在 2020 年 3 月 4 日至 4 月 9 日意大利 COVID-19 疫情高峰期,我们招募了一系列 773 名患者,由于疑似 SARS-CoV-2 感染,他们在一周内同时进行了非对比胸部 CT 和 RT-PCR。根据敏感性、特异性、阳性预测值(PPV)、阴性预测值(NPV)和诊断准确性评估 CT 的诊断性能,将 RT-PCR 作为参考标准。对 CT 扫描和 RT-PCR 结果不一致的患者以及两项检测均为阴性的患者进行了分析。
RT-PCR 检测显示总阳性率为 59.8%。CT 对 SARS-CoV-2 感染的敏感性、特异性、PPV、NPV 和准确性分别为 90.7%[95%可信区间,87.7%-93.2%]、78.8%[95%可信区间,73.8%-83.2%]、86.4%[95%可信区间,76.1%-88.9%]、85.1%[95%可信区间,81.0%-88.4%]和 85.9%[95%可信区间,83.2-88.3%]。25/66(37.6%)例 CT 阳性而 RT-PCR 阴性的患者和 12/245(4.9%)例两项检测均为阴性的患者根据临床和流行病学标准被临床医生判断为阳性病例,并因此接受治疗。
根据我们的经验,在高术前概率的情况下,CT 扫描对 COVID-19 肺炎的诊断具有良好的敏感性,特异性也高于以往研究报道,尤其是在考虑临床和流行病学特征的情况下。